Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


04.09.2017

1 AIDS
1 Am J Respir Crit Care Med
3 Antimicrob Agents Chemother
2 Eur J Clin Microbiol Infect Dis
3 Eur Respir J
11 Int J Tuberc Lung Dis
3 J Immunol
5 Lancet Infect Dis
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  2. LEWINSOHN D
    An Expanding Role for Environmental Microbes in Shaping the Immune Response to Infection with Mycobacterium Tuberculosis.
    Am J Respir Crit Care Med. 2017 Aug 25. doi: 10.1164/rccm.201708-1599.
    PubMed     Text format    


    Antimicrob Agents Chemother

  3. ARORA K, Ochoa-Montano B, Tsang PS, Blundell TL, et al
    Correction for Arora et al., "Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis".
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format    

  4. PELOQUIN CA, Velasquez GE, Lecca L, Calderon RI, et al
    Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format    

  5. VELASQUEZ GE, Calderon RI, Mitnick CD, Becerra MC, et al
    Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in MDR-TB Patients.
    Antimicrob Agents Chemother. 2016 Sep 6. pii: AAC.00632.
    PubMed     Text format     Abstract available


    Eur J Clin Microbiol Infect Dis

  6. NASIRI MJ, Zamani S, Pormohammad A, Feizabadi MM, et al
    The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 19. doi: 10.1007/s10096-017-3079.
    PubMed     Text format     Abstract available

  7. LIN HC, Perng CL, Lai YW, Lin FG, et al
    Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 24. doi: 10.1007/s10096-017-3082.
    PubMed     Text format     Abstract available


    Eur Respir J

  8. DOBLER CC, Cheung K, Nguyen J, Martin A, et al
    Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  9. LEE MR, Ho CM, Lee CH, Lee MC, et al
    Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan.
    Eur Respir J. 2017;50.
    PubMed     Text format    

  10. CAZABON D, Suresh A, Oghor C, Qin ZZ, et al
    Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    Int J Tuberc Lung Dis

  11. NATHAVITHARANA RR, Daru P, Barrera AE, Mostofa Kamal SM, et al
    FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.
    Int J Tuberc Lung Dis. 2017;21:1020-1025.
    PubMed     Text format     Abstract available

  12. YOON C, Chaisson LH, Patel SM, Allen IE, et al
    Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1013-1019.
    PubMed     Text format     Abstract available

  13. PEDRAZZOLI D, Boccia D, Dodd PJ, Lonnroth K, et al
    Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:957-964.
    PubMed     Text format     Abstract available

  14. DATIKO DG, Yassin MA, Theobald SJ, Cuevas LE, et al
    A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:1002-1007.
    PubMed     Text format     Abstract available

  15. LIAO S, Cai C, Huo FM, Wu JN, et al
    Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
    Int J Tuberc Lung Dis. 2017;21:990-995.
    PubMed     Text format     Abstract available

  16. MINH HV, Mai VQ, Nhung NV, Hoi LV, et al
    Costs of providing tuberculosis diagnosis and treatment services in Viet Nam.
    Int J Tuberc Lung Dis. 2017;21:1035-1040.
    PubMed     Text format     Abstract available

  17. COLLINS D, Hafidz F, Mustikawati D
    The economic burden of tuberculosis in Indonesia.
    Int J Tuberc Lung Dis. 2017;21:1041-1048.
    PubMed     Text format     Abstract available

  18. METCALFE J, Gerona R, Wen A, Bacchetti P, et al
    An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
    Int J Tuberc Lung Dis. 2017;21:1069-1070.
    PubMed     Text format    

  19. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Int J Tuberc Lung Dis. 2017;21:1026-1034.
    PubMed     Text format     Abstract available

  20. CENTIS R, D'Ambrosio L, Migliori GB
    Understanding the multidrug-resistant tuberculosis epidemic in China.
    Int J Tuberc Lung Dis. 2017;21:955.
    PubMed     Text format    

  21. ZENNER D, Hafezi H, Potter J, Capone S, et al
    Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:965-976.
    PubMed     Text format     Abstract available


    J Immunol

  22. CHEEKATLA SS, Tripathi D, Venkatasubramanian S, Paidipally P, et al
    IL-21 Receptor Signaling Is Essential for Optimal CD4+ T Cell Function and Control of Mycobacterium tuberculosis Infection in Mice.
    J Immunol. 2017 Aug 30. pii: ji1601231. doi: 10.4049/jimmunol.1601231.
    PubMed     Text format     Abstract available

  23. JEYANATHAN M, Afkhami S, Khera A, Mandur T, et al
    CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway.
    J Immunol. 2017 Aug 21. pii: ji1700382. doi: 10.4049/jimmunol.1700382.
    PubMed     Text format     Abstract available

  24. BUREL JG, Qian Y, Lindestam Arlehamn C, Weiskopf D, et al
    An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry.
    J Immunol. 2017;198:1748-1758.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  25. YOON C, Semitala FC, Atuhumuza E, Katende J, et al
    Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Lancet Infect Dis. 2017 Aug 25. pii: S1473-3099(17)30488.
    PubMed     Text format     Abstract available

  26. SAUNDERS MJ, Wingfield T, Tovar MA, Baldwin MR, et al
    A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study.
    Lancet Infect Dis. 2017 Aug 18. pii: S1473-3099(17)30447.
    PubMed     Text format     Abstract available

  27. MANDALAKAS AM, Cobelens F
    Tuberculosis-making predictions, especially about the future.
    Lancet Infect Dis. 2017 Aug 18. pii: S1473-3099(17)30492.
    PubMed     Text format    

  28. SALAZAR-AUSTIN N, Akinboyo I, Jain SK
    Successful cure of extensively drug-resistant pulmonary tuberculosis in a young child.
    Lancet Infect Dis. 2017;17:898-899.
    PubMed     Text format    

  29. ALFFENAAR JC, Migliori GB, Gumbo T
    Multidrug-resistant tuberculosis: pharmacokinetic and pharmacodynamic science.
    Lancet Infect Dis. 2017;17:898.
    PubMed     Text format    


    PLoS One

  30. BRUFFAERTS N, Vluggen C, Roupie V, Duytschaever L, et al
    Virulence and immunogenicity of genetically defined human and porcine isolates of M. avium subsp. hominissuis in an experimental mouse infection.
    PLoS One. 2017;12:e0171895.
    PubMed     Text format     Abstract available

  31. HATTHAKAROON C, Pharkjaksu S, Chongtrakool P, Suwannakarn K, et al
    Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand.
    PLoS One. 2017;12:e0173744.
    PubMed     Text format     Abstract available

  32. HAIMOVICH JS, Venkatesh AK, Shojaee A, Coppi A, et al
    Discovery of temporal and disease association patterns in condition-specific hospital utilization rates.
    PLoS One. 2017;12:e0172049.
    PubMed     Text format     Abstract available

  33. ESPINOSA-CUETO P, Magallanes-Puebla A, Castellanos C, Mancilla R, et al
    Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation.
    PLoS One. 2017;12:e0182126.
    PubMed     Text format     Abstract available

  34. SINGH BK, Sharma SK, Sharma R, Sreenivas V, et al
    Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis.
    PLoS One. 2017;12:e0182988.
    PubMed     Text format     Abstract available

  35. HOCHBERG NS, Sarkar S, Horsburgh CR Jr, Knudsen S, et al
    Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention.
    PLoS One. 2017;12:e0183195.
    PubMed     Text format     Abstract available

  36. CHIACCHIO T, Delogu G, Vanini V, Cuzzi G, et al
    Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    PLoS One. 2017;12:e0183846.
    PubMed     Text format     Abstract available

  37. SHENAI S, Ronacher K, Malherbe S, Stanley K, et al
    Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB.
    PLoS One. 2016;11:e0160062.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: